chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Rotator cuff syndrome
Clinical narrative: This case was reported by a physician via sales rep and described the occurrence of rotator cuff tear in a female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX (1st dose received on an unknown date without side effects). On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced rotator cuff tear, injection site erythema and injection site pain. On an unknown date, the outcome of the rotator cuff tear, injection site erythema and injection site pain were unknown. It was unknown if the reporter considered the rotator cuff tear, injection site erythema and injection site pain to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient experienced redness and pain at injection site and tore rotator cuff. The reporter did agree to be followed up from GlaxoSmithKline.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Injection site pain, Pain
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 67-year-old male patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of injection site pain (1st dose received on 1st July 2018, for tolerance see case US2018205810). On 9th November 2018, the patient received the 2nd dose of SHINGRIX. In November 2018, less than a week after receiving SHINGRIX, the patient experienced injection site pain, chills and pain. Rechallenge with SHINGRIX was positive. On an unknown date, the outcome of the injection site pain, chills and pain were unknown. It was unknown if the reporter considered the injection site pain, chills and pain to be related to SHINGRIX. Additional details were provided as follows: The patient reported that he had his dose of SHINGRIX in left arm and experienced pain at injection site, chills and achiness. The patient reported that he experienced the same adverse events on both injections. The patient planned to follow-up with his physician on an unknown date.
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Headache, Nausea, Pyrexia
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of chills in a female patient who received SHINGRIX for prophylaxis. On 25th September 2018, the patient received the 1st dose of SHINGRIX. On 25th September 2018, less than a day after receiving SHINGRIX, the patient experienced chills, fever, headache and nausea. On an unknown date, the outcome of the chills, fever, headache and nausea were unknown. It was unknown if the reporter considered the chills, fever, headache and nausea to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. On the same day of vaccination, at night, the patient experienced chills and fever. The patient also developed a severe headache and nausea that night and the entire next day. The reporter gave consent to follow-up.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: This case was reported by a other health professional via call center representative and described the occurrence of shingles in a 73-year-old female patient who received SHINGRIX (batch number L9CS4, expiry date 22nd February 2021) for prophylaxis. In August 2018, the patient received the 1st dose of SHINGRIX. In September 2018, less than a year after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were provided as follows: This case was reported by Pharmacy Technician. At the end of September 2018, the patient developed shingles. The healthcare professional wanted to know when the patient should receive the 2nd dose of SHINGRIX. The healthcare professional consented to follow up.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Gastrointestinal sounds abnormal, Myalgia
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a 58-year-old female patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included disability. On 23rd October 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 27th October 2018, 4 days after receiving SHINGRIX, the patient experienced muscle pain. On 7th November 2018, the patient experienced borborygmus. On an unknown date, the outcome of the muscle pain and borborygmus were not recovered/not resolved. It was unknown if the reporter considered the muscle pain and borborygmus to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX on left deltoid. The patient developed abdominal muscle pain 4 to 5 days later. Fifteen days after receiving SHINGRIX, the patient also hears a gurgling noise from her stomach and wonders if it might be related.
Age: 11.0
Sex: F
Vaccine: FLU4
Symptoms: Back pain, Musculoskeletal pain, Neck pain
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of shoulder pain in a 11-year-old female patient who received FLUARIX QUADRIVALENT 2018-2019 season (batch number 454G3, expiry date 30th June 2019) for prophylaxis. On 6th November 2018, the patient received FLUARIX QUADRIVALENT 2018-2019 season (intramuscular). On 7th November 2018, 1 days after receiving FLUARIX QUADRIVALENT 2018-2019 season, the patient experienced shoulder pain, neck pain, bone pain and back pain. The patient was treated with Lidocaine. On an unknown date, the outcome of the shoulder pain, neck pain, bone pain and back pain were not recovered/not resolved. It was unknown if the reporter considered the shoulder pain, neck pain, bone pain and back pain to be related to FLUARIX QUADRIVALENT 2018-2019 season. Additional details were provided as follows: The patient received FLUARIX QUADRIVALENT 2018-2019 season on left arm and the next day she experienced shoulder, neck collarbone and back pain. The patient had no fever, swelling or redness. The patient's mother gave her a Lidocaine patch, but the pain had not resolved. On 9th November 2018, the patient had a doctor's appointment. There was consent to follow up.
Age: 75.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: This case was reported by a other health professional via call center representative and described the occurrence of injection site erythema in a 75-year-old male patient who received SHINGRIX (batch number D294J, expiry date 22nd March 2021) for prophylaxis. On 2nd November 2018, the patient received the 1st dose of SHINGRIX. On 5th November 2018, 3 days after receiving SHINGRIX, the patient experienced injection site erythema, injection site swelling and injection site itching. The patient was treated with MEDROL and doxycycline. On an unknown date, the outcome of the injection site erythema, injection site swelling and injection site itching were unknown. It was unknown if the reporter considered the injection site erythema, injection site swelling and injection site itching to be related to SHINGRIX. Additional information received as follows: The case was reported by the certified medical assistant. The patient received SHINGRIX on the left arm. The patient experienced injection site reactions after receiving SHINGRIX. The reporter was inquiring if anyone else reported these events from this particular lot. She was not reporting a Pharmaceutical product complaint, she was just asking the question. The reporter gave consent to follow up. This has been linked to the case US2018204709, reported by the same reporter.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: This case was reported by a other health professional via call center representative and described the occurrence of injection site erythema in a 63-year-old female patient who received SHINGRIX (batch number D294J, expiry date 22nd March 2018) for prophylaxis. On 5th November 2018, the patient received the 2nd dose of SHINGRIX. On 5th November 2018, less than a day after receiving SHINGRIX, the patient experienced injection site swelling and injection site itching. On 8th November 2018, the patient experienced injection site erythema. The patient was treated with MEDROL and doxycycline. On an unknown date, the outcome of the injection site erythema, injection site swelling and injection site itching were unknown. It was unknown if the reporter considered the injection site erythema, injection site swelling and injection site itching to be related to SHINGRIX. Additional information received as follows: The case was reported by the certified medical assistant. The patient received SHINGRIX on the left arm. The patient experienced injection site reactions after receiving SHINGRIX. The reporter was inquiring if anyone else reported these events from this particular lot. She was not reporting a Pharmaceutical product complaint, she was just asking the question. The reporter gave consent to follow up. This has been linked to the case US2018204706, reported by the same reporter.
Age: 41.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pruritus, Rash, Vaccine positive rechallenge
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of rash in a 41-year-old female patient who received FLUARIX QUADRIVALENT 2018-2019 season (batch number EB7J7, expiry date unknown) for prophylaxis. Previously administered products included FLUARIX QUADRIVALENT vaccine with an associated reaction of rash (dose received in 2017, refer case US2018GSK211225). On 26th October 2018, the patient received FLUARIX QUADRIVALENT 2018-2019 season (intramuscular). In October 2018, less than a month after receiving FLUARIX QUADRIVALENT 2018-2019 season, the patient experienced rash. On 29th October 2018, the patient experienced injection site itching. Rechallenge with FLUARIX QUADRIVALENT 2018-2019 season was positive. On an unknown date, the outcome of the rash and injection site itching were not recovered/not resolved. It was unknown if the reporter considered the rash and injection site itching to be related to FLUARIX QUADRIVALENT 2018-2019 season. Additional information received as follows: The patient received SHINGRIX vaccine on left arm. The patient experienced itching at the injection site, which further progressed to the rash under her arm, around the back, behind the knees and all the way down to the left side of the body. The rash was progressive. The patient had an appointment scheduled with her physician at afternoon on the reporting day. Emergency room visit required. No further details were provided. The reporter gave consent to follow up.
Age: 76.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of rash in a 76-year-old female patient who received SHINGRIX (batch number EY93J, expiry date 13th April 2021) for prophylaxis. On 7th November 2018, the patient received the 2nd dose of SHINGRIX. On 7th November 2018, less than a day after receiving SHINGRIX, the patient experienced rash. On an unknown date, the outcome of the rash was unknown. It was unknown if the reporter considered the rash to be related to SHINGRIX. Additional details were provided as follows: The reporter reported that, the patient received SHINGRIX on left deltoid. Later on the day of vaccination, the patient had experienced a baseball sized rash below the injection site between the shoulder and the elbow. There was consented to follow up.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Injection site pain, Pain
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 67-year-old male patient who received SHINGRIX for prophylaxis. On 1st July 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 1st July 2018, less than a day after receiving SHINGRIX, the patient experienced injection site pain, chills and pain. On an unknown date, the outcome of the injection site pain, chills and pain were unknown. It was unknown if the reporter considered the injection site pain, chills and pain to be related to SHINGRIX. Additional details were provided as follows: The patient reported that he had his dose of SHINGRIX in right arm and experienced pain at injection site, chills and achiness. The patient reported that he experienced the same adverse events on both injections (tolerance for 2nd dose refer case US2018GSK209725). The patient planned to follow-up with his physician on an unknown date.
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Rash, Vaccination failure
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of suspected vaccination failure in a 54-year-old female patient who received SHINGRIX for prophylaxis. Co-suspect products included SHINGRIX (batch number B9739, expiry date 22nd November 2020) for prophylaxis. The patient's past medical history included shingles. Previously administered products included acyclovir (patient was on acyclovir for recurring shingles). On 1st April 2018, the patient received the 1st dose of SHINGRIX. On 10th June 2018, the patient received the 2nd dose of SHINGRIX. On 12th November 2018, 225 days after receiving SHINGRIX and 155 days after receiving SHINGRIX, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and rash. The patient was treated with acyclovir. On an unknown date, the outcome of the vaccination failure, shingles and rash were unknown. It was unknown if the reporter considered the vaccination failure, shingles and rash to be related to SHINGRIX and SHINGRIX. Additional details were provided as follows: The patient did not have shingles when she received SHINGRIX. The patient was reportedly not on acyclovir for the second dose, but she might have been on it for the first dose. The patient had since developed shingles again and started taking acyclovir again yesterday. The reporter had consented to follow up. This case was considered as suspected vaccination failure as a primary vaccination schedule and confirmatory laboratory test were not reported.
Age: 16.0
Sex: M
Vaccine: FLU4, MENB, MNQ
Symptoms: Dizziness, Fall, Headache, Loss of consciousness, Nausea
Clinical narrative: Clt fell, experienced light-headedness, brief loss of consciousness, ringing in ears, nausea, right hand shaking and mild headache. BP taken by clinic PHN 102/64. Later BP was 118/72. Per client, all symptoms resolved before leaving clinic. This PHNC advised mother to have clt evaluated by medical provider today after leaving clinic.
Age: 16.0
Sex: M
Vaccine: FLU4, MENB, MNQ
Symptoms: Tinnitus, Tremor
Clinical narrative: Clt fell, experienced light-headedness, brief loss of consciousness, ringing in ears, nausea, right hand shaking and mild headache. BP taken by clinic PHN 102/64. Later BP was 118/72. Per client, all symptoms resolved before leaving clinic. This PHNC advised mother to have clt evaluated by medical provider today after leaving clinic.
Age: 8.0
Sex: F
Vaccine: MMR
Symptoms: Rash, Rash generalised
Clinical narrative: 11/14/2018- Per parent, patient developed a non-itchy rash on face. 11/16/2018 - Per CRNP, at an urgent care facility, rash spread to entire body.
Age: 11.0
Sex: M
Vaccine: FLUC4
Symptoms: Loss of consciousness, Seizure
Clinical narrative: Vaccine was administered without issue in clinic, patient did not complain of dizziness/lightheadedness. About 15 minutes later mom reported that child had passed out and had a "seizure" in the store, EMS was called patient was alert, oriented and without injury, was released from EMS - pediatrician notified.
Age: 68.0
Sex: M
Vaccine: VARZOS
Symptoms: Erythema, Injection site pain, Injection site swelling, Swelling
Clinical narrative: Swelling, redness, swelling, and soreness at injection sight same day as injection. Five days after injection red spots on both arms and neck and hands. Reported to pharmacist Oct. 28, 2018. Selling and soreness receded in four days after injection. Red spots fading but still visible on Nov. 21, 2018.
Age: 27.0
Sex: M
Vaccine: HEP, TDAP
Symptoms: Hyperhidrosis, Pallor, Syncope, Vomiting
Clinical narrative: Patient became pale, diaphoretic and faint following 3 minutes after injection of vaccines. He vomited. He fully recovered and was able to go home.
Age: 67.0
Sex: F
Vaccine: FLUA3
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Site was red, swollen, warm, started day of vaccine, still there but now going away. Just let us know.
Age: 12.0
Sex: F
Vaccine: FLU4
Symptoms: Abdominal pain, Back pain, Blood creatine phosphokinase increased, Laboratory test, Muscular weakness
Clinical narrative: Patient had flu vaccine on 11/5/18. Went back to school and participated in gym class. The next day, patient participated in gym class again with weight lifting. The evening of 11/06/18 pt started having pain in upper body and abdominals. Pt presented to the ED on 11/9/18 for worsening symptoms. Initial labs show CK Total to be 29,376. Pt admitted to hospital and discharged on 11/11/18. Pt came to clinic for follow up care and labwork. Pt is doing better but still having muscle weakness and some back pain. Pt was diagnosed with Rhabdomyolysis.
Age: 12.0
Sex: F
Vaccine: FLU4
Symptoms: Pain, Rhabdomyolysis
Clinical narrative: Patient had flu vaccine on 11/5/18. Went back to school and participated in gym class. The next day, patient participated in gym class again with weight lifting. The evening of 11/06/18 pt started having pain in upper body and abdominals. Pt presented to the ED on 11/9/18 for worsening symptoms. Initial labs show CK Total to be 29,376. Pt admitted to hospital and discharged on 11/11/18. Pt came to clinic for follow up care and labwork. Pt is doing better but still having muscle weakness and some back pain. Pt was diagnosed with Rhabdomyolysis.
Age: 69.0
Sex: F
Vaccine: UNK
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Patient had much soreness and slight redness and slight swelling at injection site.
Age: 6.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Redness and swelling at injection site.
Sex: F
Vaccine: PPV
Symptoms: Bone pain, Musculoskeletal disorder, Pain in extremity
Clinical narrative: This spontaneous report was received from a consumer referring to herself, a 76 years old female patient. The patient's concurrent conditions include diabetes, hyperthyroidism, gastro paresis and sleep apnea and concomitant medication included insulin, atenolol, SYNTHROID, spironolactone, FLOMAX, omeprazole and PYRIDIUM. The patient reported drug reactions or allergies to pain medications and opiates, general anesthesia and sulfa. In August 2018, the patient was vaccinated with PNEUMOVAX 23 single 0.5 ml dose, intramuscular, to prevent pneumonia (anatomical site of injection, lot # and expiration date were not provided). In August 2018, the patient experienced pain in her right arm, and it felt like every bone in her body was broken from her fingertips to the base of her cranium and she had to put her arm in a sling. The patient reported that she had struggling to use her right arm so much that she cannot even pull her continuous positive airway pressure (CPAP) machine. The patient did not seek for medical attention, any laboratory test was performed and she not received any treatment for the adverse events. At the time of this report, the patient had not recovered from the adverse events. The causality assessment between PNEUMOVAX 23 and pain in extremity, musculoskeletal disorder, injected limb mobility decreased was not provided.
Sex: F
Vaccine: HPV4
Symptoms: Chronic fatigue syndrome, Depression, Persistent depressive disorder
Clinical narrative: This initial spontaneous report was received from a female patient of unknown age referring to herself. The patient reported that she had no pertinent medical history or drug reactions/allergies and that she was taking no concomitant medications. In approximately March 2013, the patient received her first dose of GARDASIL for prevention of human papilloma virus (HPV). In an unknown month in 2013, she received her second dose. In approximately June 2013, the patient received her third dose of GARDASIL (patient reported she received three doses in "Spring and Summer 2013"). Route, dose, and lot # were not provided for any of the doses. The patient stated that the third dose she received was recalled. She began to experience depression one month after receiving the third dose of GARDASIL and was started on ZOLOFT but it did not help. Four months after receiving the third dose, she started to experience dysthymia and was hospitalized on unspecified dates due to the dysthymia. On an unspecified date, she began to experience chronic fatigue syndrome "which lasted one year". The outcome of the events was not recovered/not resolved. Causality assessment was not provided. The patient was asking for compensation (not further specified). Follow-up could not be performed because the patient did not provide her contact information.
Sex: F
Vaccine: FLUX, PNC13
Symptoms: Rash
Clinical narrative: This is a spontaneous report from a contactable pharmacist received via a Pfizer sales representative. A female patient of an unspecified age (reported 69; unit unknown) received PREVNAR 13, via an unspecified route of administration in the arm on an unspecified date at a single dose for immunisation. The patient's medical history and was not reported. The patient reported taking influenza vaccine 'flu shot' that same day in a different arm for immunization. On an unspecified date in Oct2018, the patient reported a bad rash which the patient described having a puncture within the rash itself in the legs, body and back of arms. It was reported that the patient seek treatment from the physician. The outcome of the event was unknown. Information on the batch number has been requested.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Mobility decreased, Musculoskeletal pain, Neck pain, Pain in extremity, Paraesthesia
Clinical narrative: Left arm to fingers across shoulder and neck pain and tingling. Could not move arm until next morning.
Age: 3.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site rash, Peripheral swelling, Urticaria
Clinical narrative: Raised rash around injection site. Urticarial. Hives on left arm/chest and swelling of left hand.
Age: 14.0
Sex: M
Vaccine: MENB
Symptoms: Dizziness, Pyrexia
Clinical narrative: Fever of 104. Feeling faint the evening after TRUMENBA. The next day, symptoms resolved.
Age: 4.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Injection site erythema
Clinical narrative: Redness on the left arm around vaccine site, started the day of administration.
Age: 72.0
Sex: M
Vaccine: FLU4, PNC13
Symptoms: Hypoaesthesia, Pain, Pain in extremity, Paraesthesia
Clinical narrative: Patient describes tingling/numbness in shoulder developing a week after shot. Notices pain when head is turned to the right that goes down his arm on right side.
Age: 54.0
Sex: M
Vaccine: FLU4
Symptoms: Immediate post-injection reaction, Injection site swelling
Clinical narrative: Upon administration of the vaccine, pt developed significant localized swelling at administration site. Approximately the size of a marble. Pt reported no  other side effects.
Age: 52.0
Sex: F
Vaccine: FLU4
Symptoms: Condition aggravated, Palpitations, Rash, Rash pruritic
Clinical narrative: Employee states that she "I broke out in a rash one day after getting the flu shot" she also states that the rash was "itchy and painful when it first popped up on my chest". On 11/21/2018 employee states that it is no longer painful but it is still very itchy. Rash is on upper chest. Employee also states that she did have palpitations a couple of days after flu shot, she does state that she has a history of palpitations but they have never been as bad as that night.
Age: 23.0
Sex: M
Vaccine: FLU4
Symptoms: CSF myelin basic protein increased, Guillain-Barre syndrome, Hypoaesthesia, Pain, Paraesthesia
Clinical narrative: Generalized body pain, numbness/tingling in feet and legs starting 10/24/18-Gillian-Barre Syndrome.
Age: 32.0
Sex: M
Vaccine: ANTH
Symptoms: Induration, Local reaction
Clinical narrative: Dr. provider of Pt called Immunizations Clinic regarding a 2 mm induration 5 days post Anthrax injection. Informed Dr. I will enter a VAERS report post anthrax injection. Pt has no skin changes and is localized to the injection site.
Age: 62.0
Sex: F
Vaccine: FLUC4, VARZOS
Symptoms: Herpes zoster
Clinical narrative: Pt developed shingles soon after the shot on 8/29/2018. She told the pharmacy on 11/06/2018 that she had developed shingles.
Age: 20.0
Sex: F
Vaccine: MENB
Symptoms: Extra dose administered
Clinical narrative: Patient was inadvertently given a third dose of BEXSERO. Unnecessary repeat dose.
Age: 60.0
Sex: F
Vaccine: FLUX
Symptoms: Dysgeusia, Tongue discomfort
Clinical narrative: Burning sensation on tongue and metallic taste.
Age: 63.0
Sex: F
Vaccine: FLUC4, VARZOS
Symptoms: Injection site erythema, Injection site rash
Clinical narrative: Patient developed redness with rash around injection site that is about 2 inch in diameter; oval shaped area around upper left arm. Patient didn't seek any treatment. She just asked about it but I told her I would report. Told her to watch for increase in size.
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal pain upper, Chills, Headache, Influenza like illness, Muscle spasms
Clinical narrative: Extreme chills, shivering, headache, neck ache, body ached all over. Lasted all night and into the morning, gradually less severe next day, just feel like I have the flu. Stomach pain and cramping.
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Neck pain, Pain
Clinical narrative: Extreme chills, shivering, headache, neck ache, body ached all over. Lasted all night and into the morning, gradually less severe next day, just feel like I have the flu. Stomach pain and cramping.
Age: 1.42
Sex: M
Vaccine: DTAPHEPBIP, FLU4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Called mom and to see if he was having any reactions and she states that he was doing just fine and napping when I called. I told her to just keep an eye on him and call back if his symptoms change.
Age: 14.0
Sex: M
Vaccine: FLU4, HPV9
Symptoms: Dizziness, Hyperhidrosis, Immediate post-injection reaction, Injected limb mobility decreased, Injection site pain
Clinical narrative: On day of vaccines given, he felt lightheaded/dizzy/nausea and sweaty within 2 minutes after both vaccines were given in left deltoid- laid down for 20 minutes with feet elevated and given juice in office and felt better within 20 minutes. He had immediate pain at site of injection for 3 days. The next morning on 11/13/18 7 AM, he started having painful of left upper arm with movement - especially moving arm  with raising above or lowering arm and that persisted even to this day (11/21/18) - tenderness to left posterior deltoid area.
Age: 14.0
Sex: M
Vaccine: FLU4, HPV9
Symptoms: Nausea
Clinical narrative: On day of vaccines given, he felt lightheaded/dizzy/nausea and sweaty within 2 minutes after both vaccines were given in left deltoid- laid down for 20 minutes with feet elevated and given juice in office and felt better within 20 minutes. He had immediate pain at site of injection for 3 days. The next morning on 11/13/18 7 AM, he started having painful of left upper arm with movement - especially moving arm  with raising above or lowering arm and that persisted even to this day (11/21/18) - tenderness to left posterior deltoid area.
Age: 56.0
Sex: M
Vaccine: PPV
Symptoms: Cellulitis, Erythema, Impaired work ability, Malaise, Mobility decreased
Clinical narrative: Patient stated his arm was sore and hard to lift the night of injection. At work the next day it became more sore and swollen. It was also hot to the touch and red. The patient stated he was feverish and generally not feeling well. He went to urgent care and was prescribed Augmentin 875mg twice daily for 10 days to treat cellulitis. Patient missed two days of work, but stated he was feeling some better 11-21-18.
Age: 56.0
Sex: M
Vaccine: PPV
Symptoms: Pain in extremity, Peripheral swelling, Pyrexia, Skin warm
Clinical narrative: Patient stated his arm was sore and hard to lift the night of injection. At work the next day it became more sore and swollen. It was also hot to the touch and red. The patient stated he was feverish and generally not feeling well. He went to urgent care and was prescribed Augmentin 875mg twice daily for 10 days to treat cellulitis. Patient missed two days of work, but stated he was feeling some better 11-21-18.
Age: 83.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Peripheral swelling, Skin warm, Urticaria
Clinical narrative: In the evening following the injection the patient said she developed hives, Her arm puffed up and the top of the shoulder was red and hot. This reaction persisted for about 5 days then finally started to diminish with resolution after about 1.5 weeks.
Age: 78.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Pt notice her arm was red, warm, and swollen the evening after receiving her FLUZONE HD vaccine. She came to the pharmacy 2 days later and showed the pharmacist her symptoms and stated that she felt it was improving. The pharmacist did notice swelling and redness, but also noticed the location was much lower than where pt would have received her vaccine (deltoid). The reaction appeared to be more in the middle of the upper arm. I told the pt I would call her MD to explain to him the situation and that if it didn't continue to improve she should seek medical advice, At this time, I have been unable to contact the pt's doctor, but will continue to try and also told the pt to follow-up with him Friday if there was no improvement.
Age: 31.0
Sex: F
Vaccine: HEPA, TDAP, TYP
Symptoms: Alanine aminotransferase decreased, Alanine aminotransferase normal, Amylase normal, Aspartate aminotransferase normal, Blood alkaline phosphatase normal
Clinical narrative: 13 days after receiving Hepatitis A, Tdap and Typhoid injection (10/23/2018) patient showed a significant increase in LFT's. Patient denied any symptoms during that time. Was having routine labs drawn, repeat labs drawn 11/7 showed a significant decrease in LFT's.
Age: 31.0
Sex: F
Vaccine: HEPA, TDAP, TYP
Symptoms: Hepatitis viral test negative, Lipase normal, Liver function test increased, Metabolic function test abnormal, Ultrasound abdomen
Clinical narrative: 13 days after receiving Hepatitis A, Tdap and Typhoid injection (10/23/2018) patient showed a significant increase in LFT's. Patient denied any symptoms during that time. Was having routine labs drawn, repeat labs drawn 11/7 showed a significant decrease in LFT's.
Age: 16.0
Sex: M
Vaccine: FLU4
Symptoms: Extra dose administered
Clinical narrative: Client has not had any prior vaccines and coming in for as many as possible. Client was on 10/15/18 (Monday) and received an influenza vaccine along with 4 other shots. On 10/16/18 Client and parent returned to the clinic to receive more vaccines. Both parent and client was asked if he had received the flu shot the day before. Both said no. RN did not see the influenza vaccine on client's record from the day before so administered the vaccine again along with 4 more vaccines. Parent was called and informed of the second flu injection.
Age: 7.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Red warm spot 4 cm X 3 cm around injection site.
Age: 37.0
Sex: F
Vaccine: FLU4
Symptoms: Abdominal discomfort, Arthralgia, Costochondritis, Dyspnoea, Lymphadenopathy
Clinical narrative: Panic attacks including tachycardia, shortness of breath, shakiness, and gastrointestinal upset. Joint pain in areas including neck pain, hand pain, hip pain, and costochondritis. Swollen lymph nodes in neck.
Age: 37.0
Sex: F
Vaccine: FLU4
Symptoms: Panic attack, Tachycardia, Tremor
Clinical narrative: Panic attacks including tachycardia, shortness of breath, shakiness, and gastrointestinal upset. Joint pain in areas including neck pain, hand pain, hip pain, and costochondritis. Swollen lymph nodes in neck.
Age: 52.0
Sex: F
Vaccine: HEPA
Symptoms: Dysphonia, Oropharyngeal pain, Paraesthesia, Pruritus, Urticaria
Clinical narrative: Pt was given Vaccine. 10 min later stated she had hives and itching and tingling in her hands. 10 min later said her throat was sore and voice was course. Gave 50 mg IM BENADRYL. Monitored pt for 40 min post BENADRYL and symptoms resolved. Event began at approx. 09:30 AM, resolved approx. 10:40 am.
Age: 57.0
Sex: M
Vaccine: FLUC4
Symptoms: Joint range of motion decreased, Musculoskeletal pain, Pain in extremity, X-ray limb normal
Clinical narrative: Patient got flu shot on 9/26/2018. Presented back to my pharmacy 11/21/2018 with concerns. He stated that his arm was indeed sore for a day or two and then it subsided. But approximately 2 week later, his shoulder started to get sore which worsened over time and is now limiting his range of motion and causing him pain. He has been to 2 different physicians, one being a shoulder specialist and x-rays were done showing no damage to the shoulder. He has not had a flu shot for 8 to 9 years and perceives that the flu shot may be the cause of this delayed issue. He is getting medications for inflammation and pain from his physician.
Age: 72.0
Sex: F
Vaccine: FLUC4, VARZOS
Symptoms: Road traffic accident, Seizure
Clinical narrative: Patient reported having a seizure 3 1/2 days after receiving both vaccines while driving and was involved in a minor car accident (no injuries) and has had her drivers license suspended. Patient reports that it was not a gran-mal and has not been diagnosed with epilepsy but has not checked in the neurologist in some time. Patient said a brain tumor was removed 32 years ago.
Age: 40.0
Sex: M
Vaccine: FLU4
Symptoms: Heart rate normal, Immediate post-injection reaction, Injection site pain
Clinical narrative: Sharp pain immediately after injection in the arm and shoulder area. Patient was monitored for 10 minutes for an allergic reaction but none appeared. Pulse was normal. Patient was encouraged to stay for a longer period of time for monitoring but opted to go home.
Age: 32.0
Sex: F
Vaccine: FLUC4
Symptoms: Joint range of motion decreased, Pain in extremity, X-ray
Clinical narrative: In patient's words "My arm started hurting after the shot, but the pain continued to get much worse and then the pain plateaued at about 1.5 weeks. My range of motion has been extremely limited the last 6 weeks and it has been difficult to perform even the most simple task. I have received care from my primary care physician, x-rays, orthopedic, and am scheduled for physical therapy and a future MRI."
Age: 1.0
Sex: M
Vaccine: FLU4
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Pt. above was given second dose of influenza too early. Mother was notified and was told to return on 12/21/18 for second dose of influenza.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Pain, Pyrexia
Clinical narrative: Received 2nd Shigrix vaccine on 11/20/18: headache, body aches, low grade fever.
Age: 56.0
Sex: F
Vaccine: HEPA, MMR, TDAP, TYP
Symptoms: Injection site pain, Injection site swelling, Nodule, Swelling
Clinical narrative: I spoke to the patient by phone at 14:21 pm on 11/21/18. She reported that she developed pain in the injection site on the left arm shortly after receiving the vaccinations above. She also reports that she has developed swelling in the injection site without redness. In addition, patient reports left arm pit swelling and a swollen nodule in the area of her left collar bone. She denies any fever, rash or shortness of breath. Given that tomorrow is Thanksgiving, I have asked the patient to go to the nearest Urgent Care immediately for further medical evaluation and management. I also provided her with my phone number for follow-up from the provider.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Injection site erythema, Injection site rash, Pain in extremity
Clinical narrative: Very sore arm 4 hours afterwards, 14 hours afterwards very sore arm, red rash around injection site, and aching joints, continuing now 30 hours later.
Age: 71.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Patient came into pharmacy a few days later and her are was swollen and red. It was also warm to the touch. The area affect was around the injection site, in a band-like shaping wrapping around the arm about 3 to 4 inches in width. Patient was sent to MD for examination.
Age: 74.0
Sex: M
Vaccine: VARZOS
Symptoms: Dry skin, Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: Patient returned to the pharmacy 11/21/2018 and reported that the same night he received the SHINGRIX vaccination on 11/14/2018, he experienced redness and soreness at injection site, and by the next day he had heat and redness radiating down the upper arm towards the elbow. He felt that this may have been due to the fact that the pharmacist injected the vaccination slightly lower than the deltoid muscle area. He showed me his arm and it appeared slightly red with dry skin. I informed him that SHINGRIX is known to cause this reaction as one of its possible side effects even when administered perfectly. He said that his arm is feeling better than a few days ago, but just wanted to report this to us.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Body temperature increased, Foaming at mouth, Gaze palsy, Irritability, Musculoskeletal stiffness
Clinical narrative: Foster mom woke baby up from a nap for a feeding at 730PM. As she was transferring baby out of the carrier, she notes that he stiffened up and  "went into extension." He also "foamed at the mouth," producing "lots of bubbles." His eyes were "open and not moving." FM thinks that they may have been deviated to one side but she cannot quite remember. She denies jerking of the extremities and color change. She did not notice whether pt was breathing during the episode or not. She turned pt on his stomach so that he would not choke, and he remained in extension. The whole episode lasted around 30-60 seconds, per FM. It was witnessed by both her (she is a physical therapist), and a friend who is a Labor and Delivery nurse, and they both thought that it looked like seizure-like activity. This has never happened before. FM checked his temperature after the episode and it was 99.4F. After the episode, FM states that pt was "irritable and sluggish." She observed him closely for about a half an hour and then fed him, which he tolerated well. He continued to be sluggish throughout the day, and then was back to his baseline by the next day. He has been interactive, moving all extremities, and feeding well since.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Neurological examination normal, Posture abnormal, Sluggishness
Clinical narrative: Foster mom woke baby up from a nap for a feeding at 730PM. As she was transferring baby out of the carrier, she notes that he stiffened up and  "went into extension." He also "foamed at the mouth," producing "lots of bubbles." His eyes were "open and not moving." FM thinks that they may have been deviated to one side but she cannot quite remember. She denies jerking of the extremities and color change. She did not notice whether pt was breathing during the episode or not. She turned pt on his stomach so that he would not choke, and he remained in extension. The whole episode lasted around 30-60 seconds, per FM. It was witnessed by both her (she is a physical therapist), and a friend who is a Labor and Delivery nurse, and they both thought that it looked like seizure-like activity. This has never happened before. FM checked his temperature after the episode and it was 99.4F. After the episode, FM states that pt was "irritable and sluggish." She observed him closely for about a half an hour and then fed him, which he tolerated well. He continued to be sluggish throughout the day, and then was back to his baseline by the next day. He has been interactive, moving all extremities, and feeding well since.
Age: 66.0
Sex: M
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: Patients wife called to inform pharmacy that husbands arm was very painful after receiving SHINGRIX vaccination in the morning. Stated that husband had to put arm in a sling to help alleviate pain. Patient was instructed to call physician to discuss reaction to vaccine.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Injection site erythema, Injection site pain, Injection site swelling, Rash erythematous
Clinical narrative: Swelling, redness, and soreness at injection sight same day as injection. Three days after injection, red, itchy spots on neck, hands, arms, and later on forehead appeared. The spots resembled chicken pox with small blisters in the middle. Reported to pharmacist Oct. 28, 2018. Swelling and soreness receded four days after injection. Red spots fading but still visible on Nov. 21, 2018.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash pruritic, Rash vesicular
Clinical narrative: Swelling, redness, and soreness at injection sight same day as injection. Three days after injection, red, itchy spots on neck, hands, arms, and later on forehead appeared. The spots resembled chicken pox with small blisters in the middle. Reported to pharmacist Oct. 28, 2018. Swelling and soreness receded four days after injection. Red spots fading but still visible on Nov. 21, 2018.
Age: 81.0
Sex: F
Vaccine: FLUA3
Symptoms: Injection site bruising, Injection site pain
Clinical narrative: Arm had a large bruise above and below injection site. Patient stated it was slightly painful above injection site. We advised patient to contact and be seen by a doctor.
Age: 8.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Patient with area of left deltoid erythema with non discrete margins over the site of the injection. Occurred a couple of hours after injection. Approximately 24 hours after injection, still having very significant erythema, swelling, and pruritus requiring visit to clinic. Treatment with BENADRYL.
Age: 77.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Asthenia, Chills, Dizziness, Erythema, Nausea
Clinical narrative: Arm swelling, redness and pain; chills, weakness, nausea, feeling faint- symptoms lasted for 48 hours.
Age: 77.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: Arm swelling, redness and pain; chills, weakness, nausea, feeling faint- symptoms lasted for 48 hours.
Age: 75.0
Sex: M
Vaccine: FLU4, VARZOS
Symptoms: Chills, Tremor
Clinical narrative: Chills, shakes, for several days.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site reaction, Skin swelling
Clinical narrative: Pt has swollen skin around the injection site. It looks similar to cellulitis but not as deep.
Age: 32.0
Sex: F
Vaccine: FLU4
Symptoms: Joint range of motion decreased, Pain, Tendonitis
Clinical narrative: Patient experience worse pain than she has with previous vaccines with limited range of motion approximately 2 days after receiving the vaccine. Patient sought medical care and was diagnosed with inflamed tendon. She was prescribed high dose ibuprofen, which she never filled or ingested. She has had some improvement with physical therapy.
Age: 75.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Patient presented today with swelling and redness involving his entire upper left arm. He reported that it was warm to the touch and painful. I instructed him to take over the counter diphenhydramine and to contact his primary care physician.
Age: 86.0
Sex: F
Vaccine: PNC13
Symptoms: Discomfort, Erythema, Pain, Peripheral swelling, Pruritus
Clinical narrative: 11/21/18 Patient's daughter stated that patient hadn't removed the bandage provided post injection until "the other day". For at least 2 days post-vaccination, patient was fine. Then a delayed reaction occurred consisting of redness, swelling of the arm, pain, itching discomfort.
Age: 71.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site haemorrhage, Injection site pruritus, Injection site vesicles
Clinical narrative: PATIENT NOTICE SOME BLEEDING UNDER THE BARRIER BAND-AID THAT PHARMACY USED DURING THE INJECTION. SHE REPLACE IT WITH NEW BAND-AID. SOON AFTER, SHE NOTICE A DIME-SIZED BLISTER AT INJECTION SITE. SHE EXPERIENCE SOME ITCHINESS. SHE SOUGHT MEDICAL ADVICE AT EMERGENCY ROOM SINCE HER PRIMARY CARE PHYSICIAN WAS NOT AVAILABLE. DOCTOR EXPLAINED TO PATIENT THE BLISTER IS MOST LIKELY FROM THE INJECTION AND TO LET IT POP ON ITS OWN. NO MEDICATION WAS NECESSARY.
Age: 60.0
Sex: F
Vaccine: FLU4
Symptoms: Blood test normal, Brain scan normal, Computerised tomogram thorax normal, Headache, Muscular weakness
Clinical narrative: Patient developed a headache 1 day after administration. The headache did not go away until 23 days later. She developed muscle weakness on day 13. Headache was so severe on day 17 she went to instacare clinic, and then went to ER where they did bloodwork labs, brain scan, and a lung scan. Nothing abnormal. Was given oxycodone, morphine for pain. Also took ibuprofen and TYLENOL for pain. On day 23 symptoms disappeared.
Age: 11.0
Sex: M
Vaccine: FLU4
Symptoms: Fatigue, Headache, Pallor, Vision blurred
Clinical narrative: Shortly after administration of the vaccine, the patient's mother reported the patient had a headache, felt tired, was pale, and both eyes were blurry. The protocol under "Treatment of Severe Adverse Events Following Immunization Protocol" was followed and the patient was instructed to lie flat with their feet elevated. The patient's blood pressure was also taken and their blood pressure was 109/81 with a pulse rate of 49. After five minutes the patient reported feeling a little better. Another five minutes later the patient reported significant improvement and was able to stand and walk on his own. It was recommended the family stay in the store for another 15 minutes just to be safe. 15 minutes later the mother reported that the patient felt much better. The family was called four hours later to be safe and they reported no problems.
Age: 9.0
Sex: F
Vaccine: FLU4
Symptoms: Dizziness, Muscle spasms, Syncope
Clinical narrative: 3 minutes after flu vaccination, the patient reported lightheadedness and the feeling she was going to pass out in the pharmacy lobby. The patient then experienced a short episode of syncope with spasms that lasted less than 30 seconds in duration. She was supported by her father to the floor until she regained consciousness. With the help of her father, the patient was able to rise to a seated position, moved to a chair, and eventually stand/walk over the span of 25-30 minutes. No treatment requested by father during event. The pharmacy provided water to the father to give to the patient.